Blue Horseshoe Stocks: OPK, CAT & More

Opko Health, Inc. OPK

We’re going to start things off this morning by highlighting a potential bottom-bounce play in OPK which is presently boasting a ripening chart setup.

Not only that, but we’ve got a Form-4 alert on this one as well, with CEO Phillip Frost purchasing 100,000 shares yesterday at 4.89. We generally take insider buying at a bottom, especially a strong double bottom like OPK is exhibiting, as a sign that a more sustained recovery could be on the way.

We’ll place this stock on watch in the days and weeks ahead as well as keep an eye on an options idea, the OPK 03/02 $5-6 Calls.


Caterpillar Inc. CAT

Speaking of options ideas, we wanted to submit one for CAT as well in the wake of its premarket earnings release, wherein the company reported a 35% sales increase and a solid beat on profits.

The stock is gapping up into blue skies this morning in the $175 range, so we’ll be looking for a classic early dip-and-rip, and tracking the CAT Weekly $170-175 Calls for potential quick-strike trades.


Extended Watchlist:
RMGN, ATOS, CLF, MYSZ, GALT MDZ, LODE

Blue Horseshoe Stocks: Pot Stocks Heating Up Again

Pot Stocks Still Heating Up

We have literally never stopped pounding the table on our interest in marijuana related stocks for more than five years now. While we cover something in the space practically every day, occasionally we sense a greater trend coming for the sector as a whole and issue reminders to our readers accordingly. The last such post, we published on November 9th, reminding our audience that we expected a resurgence heading into 2018, which figures to be a huge year for cannabis based business in general.

We gave a list of a handful of the symbols we routinely track which included MJNA, TRTC, MJTK, AGTK, GRNH, HEMP, ACBFF, APHQF,  TWMJF, and CBIS.

GRNH and CBIS are have always been two of our favorites, although as we said, the sector as a whole will continue to be a major point of focus for us going forward. GRNH. since November 7th, has trended up from a low of .0341 to a high of .072; an increase of 111% Meanwhile, CBIS, in the same span has run from .0311 to .11, for a big 254% rise.

Some of the other fantastic moves to come out of that watchlist are as follows:

MJTK – .0005-.0028 – 460%
APHQF – 6.14-13.75 – 124%
AGTK – .0099-.0415 – 319%
ACBFF – 2.77-6.86 – 148%

These are just to name a few. Our docket of cannabis plays that we follow regularly is far too large to update all in one report, but once again, we’re going to be placing a high amount of focus on everything pot related heading into and throughout 2018.


Applied DNA Sciences, Inc. APDN

We also would like to highlight APDN, a stock that has an interesting bottom setup on the chart. As you can see on the included snapshot, the PPS has been beaten back to its lowest levels since this summer, and are hovering around a solid support level.

Couple that with the company being slated for a post-market earnings report, and we’ll be interested in tracking the activity in APDN at least through the remainder of this short week, and possibly into the upcoming short week as well.


Extended Watchlist:
ALSK, ATOS, CAG, CLNT, HMNY, WATT,

Incoming search terms:

  • mjna

Blue Horseshoe Stocks: Options Success & More

 AT&T, Inc. T – Update

As we were mentioning yesterday, AT&T was ripening for a rebound, and the stock did post a bullish session. It allowed for the beginning of what could still end up being an even more impressive move in the options contracts that we signaled for observation.

We put the T 01/19 $34-36 Calls on watch for a longer-term idea, and they got off to a good start, even as the markets in general took a turn for the worse. The solid performance of T made the following gains possible for our options calls:

$34 Calls – Range: .91-1.33 – Max Gain: 46%
$35 Calls – Range: .53-.89 – Max Gain: 68%
$36 Calls – Range: 37-.56 – Max Gain: 51%

At the present time, we still think AT&T has a ton of upside, with indicators on the chart suggesting that yesterday’s positive session was only a precursor to what could be a much bigger rebound.



Trio of Fresh Options Ideas

We’ve got a couple of daytrading ideas for the NVDA and ROKU options chains, and as we always do, we’d like to caution our readers against trading weekly options on a Friday unless you are an expert trader with disposable funds. It’s incredibly risky.

NVIDIA Corp. – NVDA Weekly $205-212.50 Calls
Roku, Inc. – ROKU Weekly $28-30 Calls

We’ve also got a fresh, longer-term idea to add to our list of tracked contracts, after noticing Price Smart was showing a strong double-bottom signal. We’ll place the following idea on watch in coming sessions.as we await this stock’s recovery.

PriceSmart, Inc. – PSMT 01/19 $80 & $85 Calls 


Extended Watchlist:
ATOS, CREG, JCP, SOGO, TOPS, RGSE, CSIQ

Blue Horseshoe Stocks: ATOS Recap & More

Atossa Genetics, Inc. ATOS

We’re coming back to ATOS for the third consecutive day this week, after our initial alert in Monday’s report, and on that morning we observed a low of .50, followed by a modest but solid run 27% to .636.

We mentioned this yesterday morning, subsequent to which point the stock launched into another bullish session. dwarfing Monday’s performance. It traded from a low of .65 right at the outset, to an afternoon high of 1.50, which works out to an intraday upswing of 130% and a two-day swing of 200%

We were also reminding readers of the conference call the company has scheduled for 10AM this morning at www.atossagenetics.com.
.


Caterpillar, Inc. CAT

Our post-earnings beat options ideas for CAT yesterday morning were the CAT Weekly $136-141 Calls. While every set of contracts did see upward movement, we’re only going to list the numbers for the $136-138′s, as the gains in the $139-141′s were minimal by comparison. We did however, see two separate chances for swing trades on the day.

$136 Calls – Swings: 2.75- 4.03 (+ 47%), 2.00-3.04 (+52%).
$137 Calls – Swings: 2.05-3.20, (+56%), 1.38-2.21 (+60%).
$138 Calls – Swings: 1.60-2.42 (+51%), .91-1.55 (+70%).

_______

Fresh Idea: Walgreens Boots-Alliance Inc. WBA

We noticed WBA this morning on the premarket earnings calendar, and in addition to exceeding expectations with their quarterly report, the stock was already looking ripe for a bottom bounce.

We’re going to signal the WBA Weekly $69-70.50 Calls for observation for the remainder of the week.


Extended Watchlist:
CAPR, GRUB, MYSZ, IRBT, NSPR, LL, XNET

Blue Horseshoe Stocks: CAT Breakout & More

PetMed Express, Inc. PETS

We signaled a longer-term options idea for PETS yesterday which needs some time to ripen, but with the solid move in the stock itself, we figured we’d recap its performance since our initial alert on it six weeks ago.

We caught PETS at a low of 32.90, which makes its 43% run to 46.94 this week that much more impressive. For a thirty-dollar stock to gain more than a third of its value in a matter of just a few weeks, is no small feat.

We’ll continue to keep our selected options, the PETS 11/17 $40-50 Calls on watch over the next few weeks.


Caterpillar, Inc. CAT

Speaking of high dollar stocks that we’ve alerted and then gone on to see impressive gains, we’ve got CAT in our sights again this morning after a solid earnings beat. We’re going to want to highlight some options ideas here as well, but first, let’s talk about the incredible bullish run of Caterpillar this year.

We were talking about this stock back in March, and that same month, the stock traded for as little as 90.34, and has essentially been in a continual uptrend ever since. Measured to this morning’s new premarket high of 141.98, it represents an increase of 57% in just over six months.

As for the options we’ll want to track on the heels of CAT’s earnings beat this morning, we’ll be looking at the CAT Weekly $136-141 Calls.


Atossa Genetics, Inc. ATOS

We’d also like to quickly recap the respectable intraday performance recorded by ATOS following our alert on the stock yesterday morning.

From an early low of .50, ATOS ran to .636 for a solid 27% move which came on more than three times the monthly average volume.

On a side note, the company has also announced that it will hold a conference call tomorrow morning at 10am EDT to discuss preliminary results from the Phase I study of its proprietary oral Endoxifen, an active metabolite of the FDA-approved breast cancer drug tamoxifen. The conference call will be available through a live webcast at www.atossagenetics.com so we’ll be sure to tune in for that.


Extended Watchlist:
HMNY, RCON, ZYNE, KNL, CEMP, DXTR